Press Releases

The approval is based on the pivotal TRIDENT-1 trial, in which AUGTYRO achieved a high response rate and durable responses, including robust intracranial responses

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the National Medical Products Administration (NMPA) in China has approved the New Drug Application (NDA) for AUGTYRO™ (repotrectinib) for the treatment of adult patients with locally... (continue reading...)

2023 Revenue of $34.87M and Gross Profit of $11.14M

TORONTO, ON / ACCESSWIRE / May 12, 2024 / Volatus Aerospace Corp. (TSXV:VOL)(OTCQB: VLTTF) ("Volatus" or "the Company"), a leader in the drone industry, is pleased to announce its financial results for the year ended Dec 31, 2023.

The Company generated revenues of $34,872,815 for the year ended Dec 31, 2023, with a 32% gross margin, and adjusted EBITDA improvement of $1,981,972 from ($5,616,940) in 2022 to ($3,634,968)... (continue reading...)

HONG KONG, May 13, 2024 - (ACN Newswire) - - Creation Business Consultants, a leading corporate services provider, tax, compliance advisory, and business consultancy firm, is thrilled to announce the opening of its new office in Hong Kong. This strategic expansion marks an exciting milestone for Creation and represents a significant opportunity for Hong Kong and Chinese clients seeking to establish their commercial presence in the Middle East.

With its rich history as a... (continue reading...)

SHANNON, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a steadfast commitment to enhancing animal patient wellbeing and accelerating healing, PBC BioVet is poised to make a significant impact in the veterinary sector.

The creation of PBC BioVet marks a pivotal moment in our company's journey. Leveraging decades of expertise in... (continue reading...)

CLEARWATER, FL - (NewMediaWire) - May 12, 2024 - REMSleep Holdings, Inc. (OTCQB: RMSL) gives an update on FDA 510(K) status.

We received the AINN Letter (FDA request for more information. The following is what we did to address FDA questions.

• Upon receiving FDA's questions, we conducted a full assessment of what was submitted vs. the Regulatory Requirements. We conducted the testing based on the current published regulatory requirements.
• We worked with our testing... (continue reading...)